Clinical Trials Browser

Phase 2 × INDUSTRY × Advanced Adult Hepatocellular Carcinoma × Clear all

NCT02409524 2020-01-22

An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects

Phase 2 Completed

Gastrointestinal

Advanced Adult Hepatocellular Carcinoma